SIRT1 and metabolic dysfunction-associated steatotic liver disease: Downregulation of miR-34a potentially contributes to altered lipid metabolism in nonalcoholic fatty liver disease (NAFLD) by regulating its targets, PPARα and SIRT1 [21].